ARIAD Pharmaceuticals Inc.

26 Landsdowne Street
Massachusetts, 02139-4234
United States
PH: 1 (617) 494 0400
Visit ARIAD Pharmaceuticals Inc. Website or Request Quote for Further Information

Primary Activity

Material Manufacturer

Company Background

ARIAD is engaged in the discovery and development of breakthrough medicines to treat cancer by regulating cell signaling with small molecules. The Company is developing a comprehensive approach to patients with cancer that addresses the greatest medical need - aggressive and advanced-stage cancers for which current treatments are inadequate. Medinol Ltd. also is developing stents and other medical devices that deliver ARIAD's lead cancer product candidate to prevent reblockage at sites of vascular injury following stent-assisted angioplasty. ARIAD has an exclusive license to pioneering technology and patents related to certain NF-(kappa)B treatment methods, and the discovery and development of drugs to regulate NF-(kappa)B cell-signaling activity, which may be useful in treating certain diseases.